QT
ALXO icon

Quantbot Technologies’s ALX Oncology ALXO Stock Holding History

Quantbot Technologies’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,600
Closed -$83.4K – 1521
2023
Q4 		$83.4K Buy
+5,600
New +$53.1K ﹤0.01% 1228
2023
Q2 		– Sell
-3,088
Closed -$14K – 1540
2023
Q1 		$14K Buy
3,088
+600
+24% +$4.54K ﹤0.01% 1385
2022
Q4 		$28K Sell
2,488
-1,400
-36% -$15.7K ﹤0.01% 1398
2022
Q3 		$37K Sell
3,888
-7,565
-66% -$88.2K ﹤0.01% 1291
2022
Q2 		$92K Buy
11,453
+4,353
+61% +$47.4K 0.01% 1165
2022
Q1 		$119K Buy
7,100
+5,480
+338% +$93.6K 0.01% 996
2021
Q4 		$34K Buy
1,620
+1,320
+440% +$56.9K ﹤0.01% 1122
2021
Q3 		$22K Buy
+300
New +$20K ﹤0.01% 1246

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Quantbot Technologies's ALXO Position: Q1 2024 in Review

Quantbot Technologies sold out of ALX Oncology (ALXO) in Q1 2024, closing a stake of 5,600 shares — an estimated $83.4K sold.

Quantbot Technologies first reported a position in ALXO in Q3 2021 and held it in 8 quarters. The position peaked at $119K in Q1 2022. 106 funds tracked by Wall St. Rank hold ALXO as of Q1 2024.

  • Quantbot Technologies reported no remaining ALX Oncology position as of Q1 2024 after selling out during the quarter.
  • Quantbot Technologies sold 5,600 ALX Oncology shares in Q1 2024, an estimated $83.4K.
  • Quantbot Technologies first reported a position in ALX Oncology in Q3 2021 and held it in 8 quarters.
  • Quantbot Technologies's ALX Oncology position peaked at $119K in Q1 2022.
  • 106 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2024.

Based on Quantbot Technologies's 13F filing for Q1 2024, filed 6 May 2024.